GW Pharmaceuticals’ cannabis-derived drug Epidyolex has been approved in Europe for two kinds of rare childhood epilepsy. The European Commission approved the drug, an oral solution containing ...

GW Pharmaceuticals ended 2017 by filing its ... GW specialises in drugs developed from cannabis plants, and already has Sativex (nabiximols) approved in markets including the UK for multiple ...

Purple Day, the international epilepsy awareness day, is today and it encourages people to wear purple and engage in ...

The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing ...

VpH & OBL set the gold standard for cannabis genetics, compliance, and regulation, paving the way for federal oversight and industry-wide accountability. HOUSTON, TX / LOS ANGELES, CA, UNITED ...

Marijuana is known for its effects on mood and perception. Some people report that they get relief from ADHD symptoms with marijuana use, but current research is inconclusive. Marijuana typically ...

4/20 In San Francisco? Here's Why SF Space Walk Should Be On Your Radar Are Marijuana Taxes Too High? They Already Beat Alcohol And Tobacco And They're About To Get Worse Mango Cannabis Launches ...

About 30 years ago, it was unimaginable for anyone to invest in a marijuana company. Now, marijuana stocks trade on some of the world’s major exchanges worldwide. The rising interest in ...

VIDEO: some retail investors have been trying to catch the proverbial ‘falling knife’ with Tesla's stock.

Healthcare & Pharmaceuticalscategory· March 21, 2025 Alnylam jumps as expanded US approval for heart disease drug fuels growth prospects Alnylam Pharmaceuticals' shares rose more than 10% on ...